Mersana Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.
CEOMartin H. Huber
CEOMartin H. Huber
Employees102
Employees102
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2001
Founded2001
Employees102
Employees102
MRSN Key Statistics
Market cap141.16M
Market cap141.16M
Price-Earnings ratio-2.00
Price-Earnings ratio-2.00
Dividend yield—
Dividend yield—
Average volume45.99K
Average volume45.99K
High today—
High today—
Low today—
Low today—
Open price$28.11
Open price$28.11
Volume0.00
Volume0.00
52 Week high$67.75
52 Week high$67.75
52 Week low$5.21
52 Week low$5.21
Stock Snapshot
The current Mersana Therapeutics(MRSN) stock price is $28.23, with a market capitalization of 141.16M. The stock trades at a price-to-earnings (P/E) ratio of -2.00.
On 2025-12-12, Mersana Therapeutics(MRSN) shares started trading at $28.11, with intraday highs of — and lows of —.
Trading volume for Mersana Therapeutics(MRSN) stock has reached 0, versus its average volume of 45.99K.
The stock's 52-week range extends from a low of $5.21 to a high of $67.75.
The stock's 52-week range extends from a low of $5.21 to a high of $67.75.
Analyst ratings
100%
of 8 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.